Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000390-20Phase 2Completed
Phase 2, randomised, double-blind trial in autoimmune colitis comparing TOP1288 with Placebo (2 arms). Primary endpoint: Endoscopic remission after 4 weeks. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000390-20.